American Healthcare REIT owns and operates senior housing, skilled nursing and medical office properties across the US, with its growth coming from a mix of acquisitions and a managed senior housing platform. Its moat is mostly scale and a diversified tenant and operator base in an asset class where demand is set by the aging population rather than the economic cycle. Revenue growth of 24.7% is the headline near-term driver, and the debate is whether that growth converts into per-share earnings, since the 6.8% operating margin and 4.0% ROE leave little room for error. At a trailing P/E of 79.4 and a forward P/E of 48.1, the market is paying for that conversion to happen, so the thesis rests on a visible step-up in earnings and funds-from-operations as acquired assets stabilize. The stock carries a score of 56/100 and no index membership, which argues for a deeper look at the cash flow bridge before any position is considered.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
ETFs we cover that hold American Healthcare REIT Inc. Common Stock among their largest holdings, by weight.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 24 Oct 2026, 17:04 CEST | Rating | Overvalued | first publication | $53.02 |
| 24 Oct 2026, 17:04 CEST | Fair value | $14.71 | $15.12 | $53.02 |
| 12 Oct 2026, 00:00 CEST | Fair value | $15.12 | $13.91 | $50.80 |
| 10 Oct 2026, 00:00 CEST | ACCE price target | $48.00 | first publication | $50.44 |
| 28 Sept 2026, 00:00 CEST | Fair value | $13.91 | $13.70 | $52.02 |
| 20 Sept 2026, 00:00 CEST | Fair value | $13.70 | $13.88 | $52.15 |
| 15 Sept 2026, 00:00 CEST | Fair value | $13.88 | $14.20 | $53.58 |
| 7 Sept 2026, 00:00 CEST | Fair value | $14.20 | $14.39 | $54.72 |
| 30 Aug 2026, 00:00 CEST | Fair value | $14.39 | $13.35 | $55.53 |
| 22 Aug 2026, 00:00 CEST | Fair value | $13.35 | $12.33 | $55.87 |
Answered from American Healthcare REIT Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| AHR American Healthcare REIT Inc. Common Stock | $53.02 | $15 | 261% above | 79.1x | 4.0% | 43 | 56 |
| DOC Healthpeak Properties Inc. Common Stock | $19.25 | - | - | 55.0x | 3.0% | 57 | 61 |
| OHI Omega Healthcare Investors Inc. Common Stock | $46.23 | $36 | 28% above | 16.5x | 16.5% | 81 | 68 |
| CTRE CareTrust REIT Inc. Common Stock | $36.62 | $21 | 75% above | 22.9x | 9.1% | 85 | 66 |
| HR Healthcare Realty Trust Incorporated Common Stock | $17.95 | $11 | 65% above | - | -1.9% | 47 | 36 |
| SBRA Sabra Health Care REIT Inc. Common Stock | $19.56 | - | - | 78.2x | 2.4% | 44 | 45 |
| NHI National Health Investors Inc. Common Stock | $67.06 | $54 | 25% above | 18.8x | 10.7% | 81 | 68 |
Where AHR ranks against its sector peers on each metric.